Showing results (251-260 of 703) with videos related to
Sort By:
Pageof 71
Gastroenterology|April 3, 2012
Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instabilityMelissa Garcia, Chan Choi, Hyeong-Rok Kim, et al.Journal of Cancer|June 18, 2019
c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal CancerRuting Xie, Yongzhi Yang, Huizhen Zhang, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2003
Identification of frame-shift intermediate mutant cellsChristoph Gasche, Christina L Chang, Loki Natarajan, et al.Oncogene|September 5, 2019
Correction: Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancerLinjie Zhao, Wei Wang, Lian Xu, et al.Oncogene|November 28, 2018
Integrative network biology analysis identifies miR-508-3p as the determinant for the mesenchymal identity and a strong prognostic biomarker of ovarian cancerLinjie Zhao, Wei Wang, Lian Xu, et al.Carcinogenesis|August 31, 2018
Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYCCharles P Hinzman, Leala Aljehane, Joshua D Brown-Clay, et al.Oncology Letters|February 14, 2018
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancerTatsuya Morikawa, Ryo Inada, Takeshi Nagasaka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2017
Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal CancerWenhao Weng, Qing Wei, Shusuke Toden, et al.Cell Death & Disease|February 4, 2018
RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinomaQingyuan Yang, Wanrun Lin, Zhiwei Liu, et al.Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated PathwayTakayuki Noma, Yuan Li, Yuma Wada, et al.Pageof 71